Your institution may have access to this item. Find your institution then sign in to continue.
Title
Phase II.
Abstract
Presents updates on Phase III clinical trials being conducted by pharmaceutical companies, as of September 2005. Preliminary results of a trial evaluating Incyte Corp.'s Reverset in treatment-experienced HIV patients who are failing their current treatment regimens; Advanced Viral Research Corp.'s addition of a fourth clinical site to its Phase II trial of AVR118 in patients with advanced cancer; NanoBio Corp.'s completion of a Phase II trial of NB-001 in patients with herpes labialis.